Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography.
Meijer D, van Leeuwen PJ, Eppinga WSC, Vanneste BGL, Meijnen P, Daniels LA, van den Bergh RCN, Lont AP, Bodar YJL, Ettema RH, de Bie KCC, Oudshoorn FHK, Nieuwenhuijzen JA, van der Poel HG, Donswijk ML, Heymans MW, Oprea-Lager DE, Schaake EE, Vis AN.
Meijer D, et al. Among authors: heymans mw.
Eur Urol Open Sci. 2024 Feb 6;61:37-43. doi: 10.1016/j.euros.2024.01.009. eCollection 2024 Mar.
Eur Urol Open Sci. 2024.
PMID: 38384437
Free PMC article.
BACKGROUND AND OBJECTIVE: Owing to the greater use of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with biochemical recurrence (BCR) of prostate cancer (PCa) after robot-assisted radical prostatectomy (RARP), pati …
BACKGROUND AND OBJECTIVE: Owing to the greater use of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomogr …